Associated Banc-Corp Has Lowered By $324,729 Its Abbott Labs (ABT) Stake; Intrepid Capital Management Trimmed By $584,595 Its Northern Tr Com (NTRS) Position

May 27, 2018 - By Adrian Erickson

Abbott Laboratories (NYSE:ABT) Logo

Associated Banc-Corp decreased Abbott Labs (ABT) stake by 2.9% reported in 2017Q4 SEC filing. Associated Banc-Corp sold 5,697 shares as Abbott Labs (ABT)’s stock rose 5.88%. The Associated Banc-Corp holds 190,426 shares with $10.87 million value, down from 196,123 last quarter. Abbott Labs now has $109.35 billion valuation. The stock decreased 0.22% or $0.14 during the last trading session, reaching $62.37. About 3.84 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since May 27, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Intrepid Capital Management Inc decreased Northern Tr Corp Com (NTRS) stake by 34% reported in 2017Q4 SEC filing. Intrepid Capital Management Inc sold 5,905 shares as Northern Tr Corp Com (NTRS)’s stock rose 2.63%. The Intrepid Capital Management Inc holds 11,465 shares with $1.15M value, down from 17,370 last quarter. Northern Tr Corp Com now has $23.99B valuation. The stock decreased 0.86% or $0.92 during the last trading session, reaching $106.61. About 495,613 shares traded. Northern Trust Corporation (NASDAQ:NTRS) has risen 19.41% since May 27, 2017 and is uptrending. It has outperformed by 7.86% the S&P500.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The stock has “Buy” rating by Stifel Nicolaus on Thursday, October 19. Morgan Stanley maintained the stock with “Equal-Weight” rating in Thursday, October 19 report. The rating was maintained by Stifel Nicolaus with “Buy” on Thursday, July 20. The stock of Abbott Laboratories (NYSE:ABT) has “Overweight” rating given on Thursday, January 25 by Morgan Stanley. On Tuesday, April 24 the stock rating was maintained by Citigroup with “Neutral”. BTIG Research downgraded Abbott Laboratories (NYSE:ABT) on Monday, January 22 to “Neutral” rating. The company was downgraded on Friday, November 13 by Goldman Sachs. BMO Capital Markets upgraded the stock to “Outperform” rating in Tuesday, December 12 report. The firm earned “Hold” rating on Thursday, August 17 by Citigroup. The company was maintained on Monday, April 17 by Cowen & Co.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.04, from 0.87 in 2017Q3. It increased, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Winslow Capital Mgmt Ltd Liability accumulated 13,460 shares. Rathbone Brothers Public Ltd accumulated 211,780 shares. Tower Research Capital Ltd Company (Trc) accumulated 13,553 shares or 0.1% of the stock. Eagle Ridge Invest Management holds 184,872 shares. Wagner Bowman Mngmt holds 0.24% of its portfolio in Abbott Laboratories (NYSE:ABT) for 15,818 shares. Inr Advisory Llc has invested 0% in Abbott Laboratories (NYSE:ABT). Verition Fund Ltd Llc holds 6,896 shares. Amica Mutual Insurance Commerce has 0.76% invested in Abbott Laboratories (NYSE:ABT) for 135,142 shares. Johnson Investment Counsel holds 1.54% or 1.08 million shares. Verity Asset Management holds 0.26% or 5,462 shares in its portfolio. Wilbanks Smith Thomas Asset Mgmt Ltd Limited Liability Company reported 24,974 shares. Mcrae Cap Inc invested 0.22% of its portfolio in Abbott Laboratories (NYSE:ABT). Spinnaker Tru owns 30,726 shares. Of Virginia Va owns 35,631 shares. Pension has invested 0.4% of its portfolio in Abbott Laboratories (NYSE:ABT).

Another recent and important Abbott Laboratories (NYSE:ABT) news was published by Streetinsider.com which published an article titled: “Stifel Sees Minimal Impact from Abbott Labs (ABT) HeartMate III ‘Dear Doc Letter'” on May 23, 2018.

Since December 14, 2017, it had 1 insider purchase, and 21 selling transactions for $23.88 million activity. On Wednesday, February 28 the insider Funck Robert E sold $71,970. Watkin Jared sold $183,579 worth of stock. BIRD ROGER also sold $518,450 worth of Abbott Laboratories (NYSE:ABT) on Friday, March 9. Salvadori Daniel Gesua Sive sold $183,592 worth of stock or 3,000 shares. Another trade for 11,106 shares valued at $667,804 was sold by Fussell Stephen R. 42,665 shares were sold by Ford Robert B, worth $2.69 million. 1,430 Abbott Laboratories (NYSE:ABT) shares with value of $84,344 were sold by MANNING JOSEPH J.

Associated Banc-Corp increased Honeywell Intl Inc (NYSE:HON) stake by 2,217 shares to 84,799 valued at $13.01M in 2017Q4. It also upped Lam Research Corp (NASDAQ:LRCX) stake by 61,877 shares and now owns 92,577 shares. International Business Machs (NYSE:IBM) was raised too.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 EPS, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24 billion for 21.96 P/E if the $0.71 EPS becomes a reality. After $0.59 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Investors sentiment increased to 1.03 in Q4 2017. Its up 0.06, from 0.97 in 2017Q3. It is positive, as 27 investors sold NTRS shares while 191 reduced holdings. 59 funds opened positions while 165 raised stakes. 175.58 million shares or 4.39% less from 183.65 million shares in 2017Q3 were reported. First Republic Invest reported 0.09% of its portfolio in Northern Trust Corporation (NASDAQ:NTRS). Advantus Management, Minnesota-based fund reported 21,771 shares. Charter Tru Communication has 0.04% invested in Northern Trust Corporation (NASDAQ:NTRS) for 3,472 shares. Tiedemann Wealth Mngmt Limited Liability Corporation reported 3,000 shares stake. Rampart Invest Commerce Ltd Liability Co reported 2,904 shares stake. Seaward Mgmt Partnership has invested 0.21% of its portfolio in Northern Trust Corporation (NASDAQ:NTRS). Daiwa Sb Invs, a Japan-based fund reported 86,200 shares. Neuberger Berman Gru Ltd Liability Com holds 0% of its portfolio in Northern Trust Corporation (NASDAQ:NTRS) for 20,413 shares. Ahl Ptnrs Ltd Liability Partnership reported 0.06% stake. Sumitomo Mitsui Asset Mngmt reported 15,654 shares stake. Ww Asset Mgmt invested 0.06% of its portfolio in Northern Trust Corporation (NASDAQ:NTRS). Alliancebernstein Limited Partnership holds 0.08% of its portfolio in Northern Trust Corporation (NASDAQ:NTRS) for 1.11M shares. Earnest Ltd reported 88,739 shares. Cortland Advisers Limited Liability Co has 436,122 shares. California State Teachers Retirement Systems accumulated 367,189 shares.

More recent Northern Trust Corporation (NASDAQ:NTRS) news were published by: Businesswire.com which released: “Northern Trust Names New Head of Sales for Asia-Pacific” on May 23, 2018. Also Businesswire.com published the news titled: “Northern Trust Bolsters Institutional Brokerage With Experienced Hire” on May 17, 2018. Businesswire.com‘s news article titled: “Northern Trust Universe Data: Flat Returns for Institutional Plan Sponsors in First Quarter of 2018” with publication date: May 15, 2018 was also an interesting one.

Among 17 analysts covering Northern Trust Corporation (NASDAQ:NTRS), 7 have Buy rating, 1 Sell and 9 Hold. Therefore 41% are positive. Northern Trust Corporation had 75 analyst reports since August 6, 2015 according to SRatingsIntel. On Thursday, January 21 the stock rating was upgraded by RBC Capital Markets to “Outperform”. The firm has “Hold” rating given on Wednesday, June 28 by Keefe Bruyette & Woods. The firm has “Hold” rating by Deutsche Bank given on Wednesday, October 5. Bank of America maintained the stock with “Buy” rating in Thursday, July 20 report. Jefferies maintained Northern Trust Corporation (NASDAQ:NTRS) rating on Monday, July 10. Jefferies has “Buy” rating and $11100 target. The company was maintained on Monday, April 9 by Sandler O’Neill. Deutsche Bank maintained Northern Trust Corporation (NASDAQ:NTRS) rating on Friday, April 6. Deutsche Bank has “Hold” rating and $111 target. Keefe Bruyette & Woods maintained Northern Trust Corporation (NASDAQ:NTRS) on Tuesday, April 17 with “Hold” rating. The rating was maintained by RBC Capital Markets with “Buy” on Wednesday, June 28. On Thursday, October 19 the stock rating was maintained by Buckingham Research with “Neutral”.

Since January 26, 2018, it had 0 buys, and 19 selling transactions for $24.19 million activity. $392,172 worth of Northern Trust Corporation (NASDAQ:NTRS) was sold by Schreuder Jana R. 10,118 shares were sold by Parker Teresa, worth $1.07 million on Friday, January 26. On Thursday, March 8 the insider BROWNE ROBERT P sold $640,740. Cohodes Jeffrey D. also sold $3.26 million worth of Northern Trust Corporation (NASDAQ:NTRS) shares. On Friday, January 26 the insider Blake Aileen B sold $315,960. $1.06 million worth of Northern Trust Corporation (NASDAQ:NTRS) was sold by Potter Stephen N. Shares for $2.10 million were sold by MORRISON WILLIAM L on Friday, February 16.

Analysts await Northern Trust Corporation (NASDAQ:NTRS) to report earnings on July, 18. They expect $1.62 EPS, up 37.29% or $0.44 from last year’s $1.18 per share. NTRS’s profit will be $364.48M for 16.45 P/E if the $1.62 EPS becomes a reality. After $1.61 actual EPS reported by Northern Trust Corporation for the previous quarter, Wall Street now forecasts 0.62% EPS growth.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>